HIV-1 integrase inhibitors: update and perspectives.
Semenova
Elena A
EA
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4255, USA.
Marchand
Christophe
C
Pommier
Yves
Y
D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D019427:HIV Integrase / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D019428:HIV Integrase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology*; D006801:Humans; D016662:Virus Integration / Q000187:drug effects / Q000235:genetics / Q000502:physiology
D019428:HIV Integrase Inhibitors; D019427:HIV Integrase